You are here: Industry Insights > COVID-19

News List

Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries worldpharmanews
April 15, 2020
Sanofi has committed to donating 100 million doses of hydroxychloroquine to 50 countries around the world, and has begun to progressively deliver the medicine to authorities that have requested it.
AstraZeneca initiates CALAVI clinical trial with Calquence against COVID-19 worldpharmanews
April 15, 2020
AstraZeneca will initiate a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib) in the treatment of the exaggerated immune response (cytokine storm) associated with COVID-19 infection in severely ill patients.
Bausch Health Initiates VIRAZOLE Study in Patients with COVID-19 americanpharmaceuticalreview
April 15, 2020
Bausch Health has initiated a clinical trial program in Canada evaluating an investigational use of VIRAZOLE® (Ribavirin for Inhalation Solution, USP) in combination ...
Lilly Begins Clinical Testing of Therapies for COVID-19 americanpharmaceuticalreview
April 15, 2020
Eli Lilly and Company has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
FDA Grants CytoSorb Emergency Use Authorization for COVID-19 Patients americanpharmaceuticalreview
April 15, 2020
CytoSorbents announced the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) of CytoSorb® for use in patients with COVID-19 infection.
EMA task force established to co-ordinate rapid regulatory action for COVID-19 medicines europeanpharmaceuticalreview
April 15, 2020
The COVID-19 EMA pandemic Task Force (COVID-ETF) will aid in the development, authorisation and safety monitoring of COVID-19 vaccines and therapeutics.
US researchers to study stem cell therapy in COVID-19 patients europeanpharmaceuticalreview
April 15, 2020
The FDA has approved a clinical trial to study COVID-19 patients administered with umbilical cord-derived mesenchymal stem cells, which should prevent lung inflmammation.
Celltrion identifies antibody candidates against Covid-19 pharmaceutical-technology
April 15, 2020
Celltrion Group has completed a neutralisation test and identified the antibody candidates that showed the most promise for neutralising the novel coronavirus, SARS-CoV-2, which causes Covid-19.
AstraZeneca to trial Calquence to treat Covid-19 patients pharmaceutical-technology
April 15, 2020
AstraZeneca is set to conduct a global clinical trial of Calquence (acalabrutinib) to treat cytokine storm that manifests in severely ill Covid-19 patients.
Sanofi and GSK partner to develop Covid-19 vaccine pharmaceutical-technology
April 15, 2020
Sanofi and GlaxoSmithKline (GSK) have signed a letter of intent for a partnership focused on developing an adjuvanted vaccine for Covid-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page